Leah Haddad
Nurse Practitioner · Fountain Valley, CANPI 1033706890
Payments from drug & device makers
Across 115 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$270
- Novartis$236
- Eisai Inc.$149
- Johnson & Johnson$139
- Incyte Corporation$120
- AbbVie$112
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,25797%
- Education$743%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 9 | $270 |
| Novartis | 13 | $236 |
| Eisai Inc. | 7 | $149 |
| Johnson & Johnson | 7 | $139 |
| Incyte Corporation | 5 | $120 |
| AbbVie | 5 | $112 |
| Astellas Pharma US Inc | 5 | $102 |
| Karyopharm Therapeutics Inc. | 4 | $93 |
| Merck | 5 | $91 |
| Myovant Sciences Inc. | 5 | $80 |
| AstraZeneca | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $59 |
| Exelixis Inc. | 2 | $52 |
| Lilly USA, LLC | 3 | $51 |
| Puma Biotechnology, Inc. | 2 | $48 |
| EMD Serono, Inc. | 3 | $42 |
| Morphosys, US Inc. | 2 | $42 |
| Pfizer | 2 | $39 |
| Coherus Oncology, Inc. | 2 | $38 |
| Boehringer Ingelheim | 2 | $38 |
| Bristol Myers Squibb | 2 | $38 |
| Bayer | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Blueprint Medicines Corporation | 1 | $31 |
| Ipsen Biopharmaceuticals, Inc | 2 | $28 |
| Dendreon Pharmaceuticals LLC | 1 | $24 |
| Fennec Pharmaceuticals, Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Sanofi | 1 | $20 |
| Organon | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| GSK | 1 | $15 |
| Gilead | 1 | $14 |
| Octapharma USA, Inc. | 1 | $14 |
| EUSA Pharma (US) LLC | 1 | $14 |
| Dova Pharmaceuticals | 1 | $12 |
How this compares
$2,331 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 18 | $147 |
| Aripiprazole | 11 | $135 |
| Escitalopram Oxalate | 16 | $132 |
| Duloxetine Hcl | 11 | $115 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fountain Valley
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.